BioNTech COVID-19 Variant Vaccine Study
COVID-19 Variant Vaccine Studies in Columbus
Aventiv Research is currently participating in an investigational COVID-19 variant study at our Columbus, Ohio location. As new COVID-19 variants continue to evolve, concerns from increased transmissibility or anticipated reduction in neutralization by antibodies generated during previous infection or vaccination have increased. Clinical trials are a crucial part of advancing medical research to combat these evolving SARS-CoV-2 variant strains.
BioNTech SARS-CoV-2 multivalent RNA Vaccine Study
The primary objective of this clinical trial is to evaluate the safety and immunogenicity of a SARS-CoV-2 multivalent RNA vaccine in the prevention of COVID-19 in healthy adults.
We are specifically looking for healthy adult volunteers who:
- are 18 through 85 years of age
- have received BNT162b2 vaccine (two-dose regimen) in either a clinical trial or as part of the government vaccination program at least 6 months prior to the first study visit and have not experienced COVID-19
- are COVID-19 vaccine naïve and have not experienced COVID-19
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for the BioNTech SARS-CoV-2 multivalent RNA vaccine clinical research study. Qualified volunteers may be compensated for time and travel.